The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
Genomics is transforming the future of modern medicine and treatment modalities across specialties
Introduces revolutionary approach to workflow management to enhance operational efficiency and optimize process efficiency
Findings likely to generate hypotheses about potential new uses of drugs
Increases Siemens’ industrial software total addressable market by $11 billion; aligns with strategic goal to accelerate customer innovation across industries
Wipro’s agents for Agentforce will elevate efficiency and customer satisfaction at healthcare companies
Amgen India investment totals $200 million through 2025
Mamilli last held the role of Chief Digital & Technology Officer and Group President for China, Brazil and Precision Animal Health at Zoetis
Hyper-automated AI is a unified framework combining AI, ML, RPA, and NLQ to streamline data extraction, quality management, transformation, and actionable insights - all on a single platform
Lilly plans to hire approximately more than 1,000 new highly-skilled team members
Subscribe To Our Newsletter & Stay Updated
